chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Injection was not administered in the left arm as required but into the left shoulder near the ligament. This resulted in severe pain and loss of motion in the left arm within 24 hours of the injection. Patient went to Urgent Care on Monday, October 9, 2023 due to the pain and loss of motion. Due to the severe pain and discomfort, patient was able to see a Othopedic PA on Monday, October 9, 2023. Patient did a follow up appointment based on an email sent to Dr. on Sunday, October 8, 2023 but was unable to see Dr. Another PA was seen at a clinic. Still with severe pain, this PA was again seen Monday, October 16, 2023. Patient was seen by the Ortho PA on Friday, October 20, 2023. Patient is unable to sleep at night due to the pain to date (11/01/2023). She did experience tingling (needles and pins) in both arms running from the shoulder toward the fingers which has subsided as of this date (11/01/2023). Multiple follow up appointments for Xrays (Monday, 9 October) and a MRI (Tuesday, October 17) have been required. Pain is still experienced throughout the day and night. Patient is unable to do basic range of motion actions without severe pain and discomfort. At this time, patient is unable to return to work due to pain in left shoulder and lack of movement in shoulder and arm. Extreme concern due to pain and discomfort and if this has caused permanent damage is of the utmost concern. I (patient) plan to return to out of town and work but concern for physical restrictions due to sever pain from immunization has created additional stress. Basic requirements such as dressing are not possible.
Pt developed itchy hives over her neck, arms, legs the day after she received H1N1 injection vaccine. She also had sensation of something stuck in her throat. Symptoms improved with BENADRYL. No difficulty breathing.
This spontaneous case reported by a consumer, describes the occurrence of pyrexia (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026L20A) for COVID-19 immunization. Concurrent medical conditions included hypertension. Concomitant products/medication included vitamins (NOS) used for an unknown indication, and high blood pressure medication. On Jan 26, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced pyrexia (fever). At the time of the report, pyrexia (fever) resolved. No treatment information provided.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients who received GARDASIL (lot#, dose and frequency unspecified, intramuscular) between 09-AUG-2014 and 06-SEP-2014. Healthcare worker stated GARDASIL had been improperly stored with a low temperature of 33.6F for 6 hours. No adverse effects reported. Healthcare worker stated currently no patient data available. This is one of several reports received from the same source. Additional information has been requested.
Throat swelling.  Trouble breathing.  Symptoms spontaneously resolved.  Lasted a few minutes.  Occurred while eating a pepper.    Has never had trouble with peppers before.
Severe blood pressure elevation post vaccine several weeks 1 to 2 weeks, scary high.  05/03/2021 blood pressure went up after Dose 2 Moderna,  no more than a week of taking the higher Dose medication then tappered back to normal dosage after a week and bounce back to normal.   Work out a plan of action with Cartiologist prior to the Dose 2.
got vaccine, had shingles again/suspected vaccination failure; shingles/had shingles again, this one is worse; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. In October 2022, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 6-Oct-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient got the vaccine and had shingles and he/she had again now. The patient stated that this one was worse. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were at the time of reporting. The follow-up could not be possible as no contact details were available.
PATIENT RECEIVED SHOT ON 2/25/2021 AND ON 3/7/2020 PT STARTED SHOWING SIGNS OF BELL'S PALSEY
Received injections apporximately 9:30 am then taken to school.  Mom notified by school at 11:00 am stating that child having difficulty breathing.  Mom picked child up from school, symptoms worsened.  Child having copious green mucous in throat and nose, difficulty speaking and breathing. Taken to ER approximately 4pm.  received IM benadryl and then po Benadryl every 4 hours for 24 hours.
Allergy attack; Did not feel good, felt like they had a really bad cold; Did not feel good, felt like they had a really bad cold; sneezing and sneezing; This is a spontaneous report from a contactable Consumer (Patient).  A female of unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot number: not provided; Expiration date: Unknown), via unspecified route of administration on 23Feb2021 at 11:30 as first dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 24Feb2021, 23 hours after that dose was administered, patient started having like an allergy attack , she was sneezing and sneezing. She did not feel good, felt like she had a really bad cold all yesterday. She felt better today but did not know if she should or should not get the second dose of the Pfizer COVID-19 Vaccine relative to these events. The outcome of the events was resolving.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Failure of pneumococcal 13-val conj vac (dipht crm197 protein); This is a spontaneous report from a contactable Health Care Professional.  A patient of an unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) on an unspecified date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. It was reported failure of pneumococcal 13-val conj vac (dipht crm197 protein). Clinical outcome was unknown at time of this report.   No follow-up attempts are needed, information about lot number cannot be obtained.; Sender's Comments: Based on the information currently available, a lack of efficacy with pneumococcal 13-valent conjugate vaccine in this patient cannot be completely excluded.  Further information like confirmative pathological/serotype results, vaccination schedule and the details on vaccine preventable disease are needed for full medical assessment.
headaches, nodulars, fatigue, numbness and weakness in upperbody , neck and arm pain--chronic
shortness of breath; coughing; headache; chills; soreness in injection arm; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing), HEADACHE (headache), CHILLS (chills), VACCINATION SITE PAIN (soreness in injection arm) and DYSPNOEA (shortness of breath) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced COUGH (coughing), HEADACHE (headache), CHILLS (chills) and VACCINATION SITE PAIN (soreness in injection arm). On 01-Mar-2021, the patient experienced DYSPNOEA (shortness of breath). On 28-Feb-2021, HEADACHE (headache) and CHILLS (chills) had resolved. At the time of the report, COUGH (coughing) had not resolved and VACCINATION SITE PAIN (soreness in injection arm) and DYSPNOEA (shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient was taking treatment with tylenol, mucinex pm. Patient was taking high blood pressure medication and cholesterol medication concomitantly
Initial report received on 26 January 2007, from another manufacturer, under the reference number B0454855A, concerning a patient. A 12 year old female patient, was enrolled in the other manufacturers study and received on 04 January 2007 a dose of Menactra (lot number U2091AA) intramuscular intro the left upper deltoid and the first dose of study vaccine of Gardasil (lot number DHPVA017A). Since 16 January 2007, since 12 days post administration, the patient had been experiencing pneumonia and developed erythema multiforme and was hospitalized. The patient had been to th e(study) office two days prior to admission with fever, swollen lips and vaginal itch. Exam failed to reveal significant findings other than rales over left posterior lung fields (urine analysis and chest X ray were normal). A clinical diagnosis of rash fitting description of erythema multiform was made. The patient was discharged with symptomatic treatment. She was seen in emergency room the next day and admitted on 18 January 2007 for intravenous treatment (rochepin). The event was unresolved at the time of reporting. The other manufacturer's investigator considered that there was a reasonable possibility that th erythema multiforme may have been caused by Gardasil and Menactra and was due to pneumonia.
Patient received a vaccine past the 30 day storage on the refrigerator; Patient vaccinated with vial that expired on 25-MAR-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient vaccinated with vial that expired on 25-MAR-2022) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination.     Patient don't have allergies. Patient didn't had COVID-19 within last month.  Concurrent medical conditions included Diabetes, Hyperlipidemia, Hypertension and Cardiac murmur. Concomitant products included METFORMIN, LISINOPRIL, GLIPIZIDE, LOVASTATIN, AMLODIPINE, MELOXICAM, SITAGLIPTIN PHOSPHATE (JANUVIA), ASPIRIN [ACETYLSALICYLIC ACID] and LORATADINE for an unknown indication.    On 13-Apr-2022 at 3:16 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2022 at 3:16 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient vaccinated with vial that expired on 25-MAR-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient vaccinated with vial that expired on 25-MAR-2022) and PRODUCT STORAGE ERROR (Patient received a vaccine past the 30 day storage on the refrigerator) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Date the vial was initially stored in the refrigerator: 25-FEB-2022 Vial didn't undergo any temperature excursions. Patient not experienced any side effects yet. No Treatment information was reported.
Death - less than 24 hours after 2nd dose of Covid19 - Pfizer vaccination
patient called approximately 1 hour after getting shot and reported she could not feel her face and was on her way to the ER. No other issues except for a "heart jump" which she stated tended to happen with every shot she received.
pt develped delayed local reaction at the site of injection measuring 6 cm by 9cm.  Erythematous and pruritic as well as tender.
Arm could not move to the back/ lasted for more than one month, but did not affect the hand function; Sore arm; Fever (102); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Arm could not move to the back/ lasted for more than one month, but did not affect the hand function), VACCINATION SITE PAIN (Sore arm) and PYREXIA (Fever (102)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced PYREXIA (Fever (102)). On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Arm could not move to the back/ lasted for more than one month, but did not affect the hand function) and VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Arm could not move to the back/ lasted for more than one month, but did not affect the hand function), VACCINATION SITE PAIN (Sore arm) and PYREXIA (Fever (102)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, Body temperature: 102 (High) Had fever of 102.         No Concomitant product use was reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up was received and contains no new information. On 25-Aug-2021: Non significant follow-up received.
As the day and evening progressed, severe stiffness and tenderness at the injection site.  Painful, reactive axillary lymph nodes.  Late in the evening, severe, right-sided migraine headache occurred, which then became intense pain and pressure in whole head.  Woke morning of 4/7/22 (the day after vaccination) with low-grade fever of 99.7F.
This spontaneous report as received from a female pharmacist in her 50's reporting on herself, who on an unknown date was vaccinated subcutaneously with a 0.65 ml standard dose of ZOSTAVAX (lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that on an unknown date, she experienced a rash after getting ZOSTAVAX. No lab diagnostics studies were performed. Cortisone cream was given as a treatment for the experience (it was mentioned but was not completely sure). At the time of the report, the patient had recovered. The patient did not seek medical attention. The relatedness for patient experienced a rash was unknown for ZOSTAVAX. Additional information has been requested.
Local erythema, swelling at site, chills, body aches. Symptoms 24 hours.
Pt recvd 3rd dose of vax 11FEB92 & lab eval during that time revealed that hemoglobin was dec. lab eval on 23APR92 revealed that Anti-HBs titer was 0.9; no further details were provided;
Pt complained of "funny feeling" in her throat, which she later attributed to mucus. No stridor, SOB, wheezing, CP, LH, N/V/D, hives, LH.  While being evaluated, VS showed BP 207/124, HR 110s, afebrile.   No HA, focal neuro sxs, back pain. Pt has h/o of HTN and took her 3/4 of her dose of HCTZ this AM due to concerns about needing to urinate excessively while out getting her vaccine.  Review of her chart reveals that her BP usually run 130-150s on just HCTZ.    Pt sent to the ER for evaluation of hypertensive urgency.
pt recv vax 4FEB97 & 5FEB97 pt devel red marks on arms, trunk & legs & inflammation @ the inj site;
This is a spontaneous report obtained from a contactable nurse manager. A 16-year-old female patient received, on 06Oct2016, TRUMENBA, (Lot. N16808, Expiration date: Jul2017) at 03:09 PM, intramuscular, in the right deltoid, at 0.5 ml, single dose; MENACTRA, (Manufacturer: Sanofi, Lot. U1693AB) intramuscular, at1 DF, single dose; and FLUZONE, (Manufacturer: Sanofi, Lot. U1693AB) intramuscular, at 1 DF, single dose; all for immunization. Relevant medical history and concomitant medications were none. On 06Oct2016, the patient experienced horrendously swollen left eye, allergic reaction, headache, fever (low grade fever of 100 to 101 Fahrenheit) and her left side of the face was swollen. Doctor visit was required for eye swollen and fever on 08Oct2016; then returned with a headaches so the patient had two visits. Treatment received were the following: Tylenol, probably two 325 mg tablets (she was not sure of it) (from 06Oct2016 and ongoing) and hydroxyzine 25 mg, tablet, one tablet every 8 hours as needed (from 08Oct2016, she was not taking it right now). The patient did not recover from the event, headache; while clinical outcome of the other events was recovering.
exposed to a low temperature of 31.5 degrees Fahrenheit; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 11-month-old male patient who received HAV (Havrix) (batch number PB5JA, expiry date 14-FEB-2025) for prophylaxis.   In JUN-2023, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced incorrect storage of drug (Verbatim: exposed to a low temperature of 31.5 degrees Fahrenheit). The outcome of the incorrect storage of drug was unknown.   Additional Information: Receipt Date: 03-AUG-2023 Nurse reported that patient was administered with Havrix vaccine. On 15Jun2023 vaccine was exposed to a low temperature of 31.5 degrees Fahrenheit . The reporter was not sure on which date vaccine was administered.  According to reporter it was administered between 15Jun2023 and 21Jun2023. At the time of reporting, the dose has not been repeated. The vaccine administration facility was the same as primary reporter. The patient was administered with vaccine which was stored at low temperature which led to, Incorrect storage of drug. The reporter consented to follow up. This is 1 of 8  linked report, reported by same reporter.; Sender's Comments:  US-GSK-US2023105916:same reporter US-GSK-US2023105921:same reporter US-GSK-US2023105918:same reporter US-GSK-US2023105928:same reporter US-GSK-US2023105926:same reporter US-GSK-US2023105927:same reporter US-GSK-US2023105923:same reporter US-GSK-US2023105917:same reporter
Every night since the vaccine,  my hands go numb in the middle of the night and some times throughout the day. This wakes me up every night and I have to flex my hands for a few minutes to regain feeling. I've noticed that this happens regardless of my sleeping position and hand placement.   I have yet to be seen for these symptoms.
Herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 73 year old male patient. No information was provided regarding concomitant medications, concurrent conditions or medical history. In April 2017, when the pt was 71 years old, he was vaccinated with zoster vaccine live (ZOSTAVAX) for long term prevention of shingles and zoster-related conditions. On an unknown date, the patient experienced herpes zoster resulting from zoster vaccine live (ZOSTAVAX) use. The pt received treatment from a healthcare provider at the facility. The pt claimed damages as result of injuries, loss of consortium and services and economic losses. The outcome of herpes zoster was unknown. The reporter considered herpes zoster to be related to Zoster Vaccine Live(ZOSTAVAX).
In October legs began to stiffen while walking. Heart began to hurt, and trouble breathing. Told primary Dr.. Refereed to specialist. Ultra sound heart and major arteries, nuclear heart test done. Jan 7 heart, leg angiogram. Threw up 5 hours after booster 12/06/2021 threw up again 12/11/2021, can barley walk severe stiffness in legs pain. Trouble breathing referred to pulmonary specialist.
she still has some eruptions on her legs and stomach; headache; hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad; itching really bad; her face swelled up, like a big pumpkin; severe cramping in her back and some in her stomach; her whole left arm swelled up and was humongous; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (her whole left arm swelled up and was humongous), URTICARIA (hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad), PRURITUS (itching really bad), SWELLING FACE (her face swelled up, like a big pumpkin) and MUSCLE SPASMS (severe cramping in her back and some in her stomach) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Kidney cancer, Solitary kidney, COPD, Asthma, Arthritis, Hypertension, Anxiety and Difficulty sleeping. Concomitant products included TRAMADOL for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PERIPHERAL SWELLING (her whole left arm swelled up and was humongous). On 04-Mar-2021, the patient experienced URTICARIA (hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad), PRURITUS (itching really bad), SWELLING FACE (her face swelled up, like a big pumpkin), MUSCLE SPASMS (severe cramping in her back and some in her stomach) and HEADACHE (headache). On an unknown date, the patient experienced RASH (she still has some eruptions on her legs and stomach). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 11-Mar-2021, PERIPHERAL SWELLING (her whole left arm swelled up and was humongous), URTICARIA (hives across her chest in the lung area, neck area, back and top of her arms and it was itching really bad), PRURITUS (itching really bad), SWELLING FACE (her face swelled up, like a big pumpkin), MUSCLE SPASMS (severe cramping in her back and some in her stomach) and HEADACHE (headache) had resolved. At the time of the report, RASH (she still has some eruptions on her legs and stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medication included unspecified medicines for heart, anxiety, sleep and high blood pressure.